First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study

Ying Liu(Zhengzhou University), Jufeng Wang(Zhengzhou University), Ke Li(Xi'an University of Science and Technology), Lei Qiao(State Key Laboratory for Innovation and Transformation of Luobing Theory), Feng Wang(First Affiliated Hospital of Zhengzhou University), Han Yue(Zhengzhou People's Hospital), Shuning Xu(Zhengzhou University), Ning Ma(First Affiliated Hospital of Zhengzhou University)
International Journal of Clinical Oncology
February 24, 2015
Cited by 31


Related Papers